117 related articles for article (PubMed ID: 29994907)
1. A Proposal for a Classification for Recurrent Endometrial Cancer: Analysis of a French Multicenter Database From the FRANCOGYN Study Group.
Bricou A; Bendifallah S; Daix-Moreux M; Ouldamer L; Lavoue V; Benbara A; Huchon C; Canlorbe G; Raimond E; Coutant C; Graesslin O; Collinet P; Carcopino X; Touboul C; Daraï E; Carbillon L; Ballester M;
Int J Gynecol Cancer; 2018 Sep; 28(7):1278-1284. PubMed ID: 29994907
[TBL] [Abstract][Full Text] [Related]
2. Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group.
Bendifallah S; Ouldamer L; Lavoue V; Canlorbe G; Raimond E; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Gynecol Oncol; 2017 Jan; 144(1):107-112. PubMed ID: 27789083
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.
Topfedaisi Ozkan N; Meydanlı MM; Sarı ME; Demirkiran F; Kahramanoglu I; Bese T; Arvas M; Şahin H; Haberal A; Celik H; Coban G; Oge T; Yalcin OT; Akbayır Ö; Erdem B; Numanoğlu C; Özgül N; Boyraz G; Salman MC; Yüce K; Dede M; Yenen MC; Taşkın S; Altın D; Ortaç UF; Aydın Ayık H; Şimşek T; Güngör T; Güngördük K; Sancı M; Ayhan A
J Gynecol Oncol; 2017 Sep; 28(5):e65. PubMed ID: 28657226
[TBL] [Abstract][Full Text] [Related]
4. Change in hazard rates of recurrence over time following diagnosis of endometrial cancer: An age stratified multicentre study from the FRANCOGYN group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Bricou A; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2018 Dec; 44(12):1914-1920. PubMed ID: 30217355
[TBL] [Abstract][Full Text] [Related]
5. Incidence, patterns and prognosis of first distant recurrence after surgically treated early stage endometrial cancer: Results from the multicentre FRANCOGYN study group.
Ouldamer L; Bendifallah S; Body G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Bricou A; Lavoué V; Lévêque J; Daraï E; Ballester M;
Eur J Surg Oncol; 2019 Apr; 45(4):672-678. PubMed ID: 30722948
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer recurrence: Proposal for a classification based on anatomical dissemination pathways and prognosis.
Bendifallah S; de Foucher T; Bricou A; Ouldamer L; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Huguet F; Graesslin O; Touboul C; Collinet P; Huchon C; Daraï E; Ballester M;
Surg Oncol; 2019 Sep; 30():40-46. PubMed ID: 31500783
[TBL] [Abstract][Full Text] [Related]
7. Tumor Size, an Additional Prognostic Factor to Include in Low-Risk Endometrial Cancer: Results of a French Multicenter Study.
Canlorbe G; Bendifallah S; Laas E; Raimond E; Graesslin O; Hudry D; Coutant C; Touboul C; Bleu G; Collinet P; Cortez A; Daraï E; Ballester M
Ann Surg Oncol; 2016 Jan; 23(1):171-7. PubMed ID: 25952272
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value and Risk Factors of Peritoneal Carcinomatosis Recurrence for Patients with Endometrial Cancer: A Multicenter Study from the FRANCOGYN Group.
Gaudet Chardonnet A; Azaïs H; Ballester M; Raimond E; Bendifallah S; Ouldamer L; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Lavoue V; Koskas M; Uzan C; Canlorbe G
Ann Surg Oncol; 2021 Jan; 28(1):212-221. PubMed ID: 32648177
[TBL] [Abstract][Full Text] [Related]
9. Use of Aggressive Surveillance for Locoregional Endometrial Cancer After Local Therapy.
Yalamanchi P; Shabason JE; Zhang X; Ko EM; Lin LL
Int J Gynecol Cancer; 2018 Sep; 28(7):1264-1270. PubMed ID: 30036223
[TBL] [Abstract][Full Text] [Related]
10. Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.
de Foucher T; Bendifallah S; Ouldamer L; Bricou A; Lavoue V; Varinot J; Canlorbe G; Carcopino X; Raimond E; Monnier L; Graesslin O; Touboul C; Collinet P; Neveu ME; Huchon C; Daraï E; Ballester M;
Eur J Surg Oncol; 2019 Apr; 45(4):659-665. PubMed ID: 30685326
[TBL] [Abstract][Full Text] [Related]
11. Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group.
Reboux PA; Azaïs H; Canova CH; Bendifallah S; Ouldamer L; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Ballester M; Lévêque J; Lavoué V; Koskas M; Uzan C; Canlorbe G
J Gynecol Oncol; 2019 Jul; 30(4):e53. PubMed ID: 31074238
[TBL] [Abstract][Full Text] [Related]
12. Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro): A Korean Multicenter Study.
Kim M; Choi C; Kim K; Lim MC; Park JY; Hong JH; Lee M; Paek J; Seoung J; Lee S; Lee TS
Int J Gynecol Cancer; 2018 Jul; 28(6):1123-1129. PubMed ID: 29664841
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.
Cuylan ZF; Oz M; Ozkan NT; Comert GK; Sahin H; Turan T; Akbayir O; Kuscu E; Celik H; Dede M; Gungor T; Meydanli MM; Ayhan A
J Obstet Gynaecol Res; 2018 Jun; 44(6):1140-1149. PubMed ID: 29516573
[TBL] [Abstract][Full Text] [Related]
14. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
15. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival.
Obermair A; Manolitsas TP; Leung Y; Hammond IG; McCartney AJ
Gynecol Oncol; 2004 Mar; 92(3):789-93. PubMed ID: 14984942
[TBL] [Abstract][Full Text] [Related]
16. Honing the classification of high-risk endometrial cancer with inclusion of lymphovascular space invasion.
Bendifallah S; Perrin M; Ouldamer L; Lavoué V; Canlorbe G; Raimond E; Hudry D; Coutant C; Graesslin O; Touboul C; Collinet P; Daraï E; Ballester M;
Surg Oncol; 2017 Mar; 26(1):1-7. PubMed ID: 28317578
[TBL] [Abstract][Full Text] [Related]
17. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
Ayhan A; Taskiran C; Celik C; Yuce K
Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
[TBL] [Abstract][Full Text] [Related]
18. Liver recurrence in endometrial cancer: a multi-institutional analysis of factors predictive of postrecurrence survival.
Toptas T; Karalok A; Ureyen I; Tasci T; Erol O; Bozkurt S; Tulunay G; Simsek T; Turan T
Clin Exp Metastasis; 2016 Oct; 33(7):707-15. PubMed ID: 27339214
[TBL] [Abstract][Full Text] [Related]
19. Management and Survival of Elderly and Very Elderly Patients with Endometrial Cancer: An Age-Stratified Study of 1228 Women from the FRANCOGYN Group.
Poupon C; Bendifallah S; Ouldamer L; Canlorbe G; Raimond E; Hudry N; Coutant C; Graesslin O; Touboul C; Collinet P; Bricou A; Huchon C; Daraï E; Ballester M; Levêque J; Lavoue V
Ann Surg Oncol; 2017 Jun; 24(6):1667-1676. PubMed ID: 28008573
[TBL] [Abstract][Full Text] [Related]
20. Oncologic Outcomes After Adjuvant Radiotherapy for Stage II Endometrial Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-10).
Jung J; Kim YS; Joo JH; Park W; Lee JH; Kim JH; Yoon WS; Lee SH; Eom KY; Kim YB
Int J Gynecol Cancer; 2017 Sep; 27(7):1387-1392. PubMed ID: 28604455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]